Literature DB >> 19369328

Enumeration of an extremely high particle-to-PFU ratio for Varicella-zoster virus.

John E Carpenter1, Ernesto P Henderson, Charles Grose.   

Abstract

Varicella-zoster virus (VZV) is renowned for its low titers. Yet investigations to explore the low infectivity are hampered by the fact that the VZV particle-to-PFU ratio has never been determined with precision. Herein, we accomplish that task by applying newer imaging technology. More than 300 images were taken of VZV-infected cells on 4 different samples at high magnification. We enumerated the total number of viral particles within 25 cm(2) of the infected monolayer at 415 million. Based on these numbers, the VZV particle:PFU ratio was approximately 40,000:1 for a cell-free inoculum.

Entities:  

Mesh:

Year:  2009        PMID: 19369328      PMCID: PMC2698559          DOI: 10.1128/JVI.00081-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  CELL-FREE VARICELLA-ZOSTER VIRUS IN TISSUE CULTURE.

Authors:  A E CAUNT; D TAYLOR-ROBINSON
Journal:  J Hyg (Lond)       Date:  1964-12

2.  Electron microscopic particle counts on herpes virus using the phosphotungstate negative staining technique.

Authors:  D H WATSON; W C RUSSELL; P WILDY
Journal:  Virology       Date:  1963-03       Impact factor: 3.616

3.  Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid.

Authors:  T H WELLER; M B STODDARD
Journal:  J Immunol       Date:  1952-03       Impact factor: 5.422

4.  Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice.

Authors:  R A Santos; C C Hatfield; N L Cole; J A Padilla; J F Moffat; A M Arvin; W T Ruyechan; J Hay; C Grose
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

5.  Egress of alphaherpesviruses: comparative ultrastructural study.

Authors:  H Granzow; B G Klupp; W Fuchs; J Veits; N Osterrieder; T C Mettenleiter
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

Review 6.  Mutagenesis of the varicella-zoster virus genome: lessons learned.

Authors:  J I Cohen
Journal:  Arch Virol Suppl       Date:  2001

7.  Discordant varicella-zoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles.

Authors:  Johnathan Storlie; John E Carpenter; Wallen Jackson; Charles Grose
Journal:  Virology       Date:  2008-10-26       Impact factor: 3.616

8.  Egress of varicella-zoster virus from the melanoma cell: a tropism for the melanocyte.

Authors:  R Harson; C Grose
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  Egress of light particles among filopodia on the surface of Varicella-Zoster virus-infected cells.

Authors:  John E Carpenter; Jennifer A Hutchinson; Wallen Jackson; Charles Grose
Journal:  J Virol       Date:  2008-01-09       Impact factor: 5.103

10.  Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.

Authors:  J F Moffat; L Zerboni; P R Kinchington; C Grose; H Kaneshima; A M Arvin
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

View more
  48 in total

1.  Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo.

Authors:  Rodolphe Suspène; Marie-Ming Aynaud; Stefanie Koch; David Pasdeloup; Marc Labetoulle; Barbara Gaertner; Jean-Pierre Vartanian; Andreas Meyerhans; Simon Wain-Hobson
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Autophagosome formation during varicella-zoster virus infection following endoplasmic reticulum stress and the unfolded protein response.

Authors:  John E Carpenter; Wallen Jackson; Luca Benetti; Charles Grose
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  Particle-to-PFU ratio of Ebola virus influences disease course and survival in cynomolgus macaques.

Authors:  Kendra J Alfson; Laura E Avena; Michael W Beadles; Hilary Staples; Jerritt W Nunneley; Anysha Ticer; Edward J Dick; Michael A Owston; Christopher Reed; Jean L Patterson; Ricardo Carrion; Anthony Griffiths
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

4.  Infection and Functional Modulation of Human Monocytes and Macrophages by Varicella-Zoster Virus.

Authors:  Megan Steain; Barry Slobedman; Allison Abendroth; Jarrod J Kennedy
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

5.  Varicella-Zoster Virus ORF9p Binding to Cellular Adaptor Protein Complex 1 Is Important for Viral Infectivity.

Authors:  Marielle Lebrun; Julien Lambert; Laura Riva; Nicolas Thelen; Xavier Rambout; Caroline Blondeau; Marc Thiry; Robert Snoeck; Jean-Claude Twizere; Franck Dequiedt; Graciela Andrei; Catherine Sadzot-Delvaux
Journal:  J Virol       Date:  2018-07-17       Impact factor: 5.103

6.  Aberrant virion assembly and limited glycoprotein C production in varicella-zoster virus-infected neurons.

Authors:  Charles Grose; Xiaoli Yu; Randall J Cohrs; John E Carpenter; Jacqueline L Bowlin; Don Gilden
Journal:  J Virol       Date:  2013-06-26       Impact factor: 5.103

7.  Synthesis and decay of varicella zoster virus transcripts.

Authors:  Yevgeniy Azarkh; Lars Dölken; Maria Nagel; Don Gilden; Randall J Cohrs
Journal:  J Neurovirol       Date:  2011-04-12       Impact factor: 2.643

8.  Myelin-associated glycoprotein mediates membrane fusion and entry of neurotropic herpesviruses.

Authors:  Tadahiro Suenaga; Takeshi Satoh; Pranee Somboonthum; Yasushi Kawaguchi; Yasuko Mori; Hisashi Arase
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  COMMENTARY: Significantly less anti-gC antibody detectable in sera collected after varicella vaccination than after the disease varicella.

Authors:  Charles Grose; Young Juhn
Journal:  Pediatr Infect Dis J       Date:  2012-11       Impact factor: 2.129

10.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.